Breaking News

G1 Therapeutics Inc (GTHX)

NASDAQ

Add to/Remove from a Portfolio Add to Watchlist

4.375 +0.245 +5.93%

17:40:18 - Real-time Cboe. Currency in USD ( Disclaimer )

Volume: 414,172
Bid/Ask: 0.000 / 0.000
Day's Range: 4.150 - 4.510

Type: Equity

Market: United States

G1 Therapeutics Company Profile

Read the G1 Therapeutics Inc company profile to learn more about the business and the management team. View G1 Therapeutics Inc facts about employee data, company products and services, and contact information.

IndustryBiotechnology & Medical Research

SectorHealthcare

Employees

100

Equity Type

ORD

G1 Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer in the United States. The company offers COSELA, which helps to decrease incidence of chemotherapy-induced myelosuppression in adult patients treated with a platinum/etoposide-containing regimen or topotecan-containing regimen for extensive stage small cell lung cancer. It is also developing Trilaciclib that is in Phase 3 clinical trial for 1L metastatic triple negative breast cancer (mTNBC); and Phase 2 clinical trial as an antibody-drug conjugate combination trial in mTNBC, as well as completed Phase 2 clinical trial for Neoadjuvant TNBC and 1L Bladder cancer. The company has a license agreement with Genor Biopharma Co. Inc. for the development and commercialization of lerociclib using an oral dosage form to treat various indication in humans; Incyclix for the development and commercialization of a CDK2 inhibitor for all human and veterinary uses; and Simcere Pharmaceutical Co., Ltd for the development and commercialization of trilaciclib in all indications. G1 Therapeutics, Inc. was incorporated in 2008 and is headquartered in Research Triangle Park, North Carolina.

Contact Information

Address 700 Park Offices Drive Suite 200
Research Triangle Park, 27709
United States

Phone 919 213 9835

Fax 919 741 5830

Web www.g1therapeutics.com

Top Executives

Name	Age	Since	Title
Garry A. Nicholson	66	2018	Independent Chairman of the Board
John E. Bailey	56	2020	CEO, President & Director
Glenn P. Muir	64	2015	Independent Director
Jacks Lee	58	2022	Independent Director
Seth A. Rudnick	74	2014	Member of Clinical Advisory Board
Norman E. Sharpless	56	2022	Director
Kwok-Kin Wong	-	-	Co-Founder & Member of Scientific Advisory Board
Gary H. Lyman	77	-	Scientific & Clinical Advisor
Geoffrey I. Shapiro	-	-	Scientific & Clinical Advisor
Alicia Secor	60	2021	Independent Director
Cynthia L. Flowers	63	2018	Independent Director
Donald P. McDonnell	-	-	Scientific & Clinical Advisor

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com UK's comment guidelines and agree to the terms described.

I Agree

GTHX Price Commentary

Write your thoughts about G1 Therapeutics Inc

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

just trader Jun 22, 2021 13:19

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

G1 Therapeutics Cosela is FDA approved drug. One course cost 34 000$ and current target audince is more than 30 000 patients per year. Given near 80% margin it results in potential operationg profit per year of more than 800 mln (34k x 30k x 0,8). But with further FDA approvals for another cancer types target audience will be more than 400k patients. So, you can recalculate potential profitability.Main reason why i'm writing this is that current capitalisation is near 900mln. Analysts target prices are 2,5-4x from current price, but I think that it is much more undervalued and at least 6-7x rise will just give reasonable price to this company. What do you think of this?

1 0

Report

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="210266873">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="210266873" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="210266873" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d51-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="210266873">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d51-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d51-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

FTSE 100	8,172.15	+50.91	+0.63%
DAX	17,905.58	-26.59	-0.15%
Euro Stoxx 50	4,890.35	-30.87	-0.63%
S&P 500	5,036.84	+18.45	+0.37%
Nikkei 225	38,210.50	-40.00	-0.10%
Dow Jones	38,043.84	+140.55	+0.37%
FTSE 100 Futures	8,182.8	+55.4	+0.68%

Brent Oil	83.68	+0.24	+0.29%
Crude Oil WTI	79.01	+0.01	+0.01%
Gold	2,311.35	+0.35	+0.02%
Silver	26.828	+0.080	+0.30%
Copper	4.4828	-0.0632	-1.39%
London Cocoa	7,047.00	-761.00	-9.75%
London Wheat	179.90	+0.55	+0.31%

U.K. 10Y	4.3310	+0.0410	+0.96%
U.K. 5Y	4.2140	+0.0370	+0.89%
U.K. 2Y	4.4550	+0.0340	+0.77%
Germany 10Y	2.5370	-0.0160	-0.63%
U.S. 10Y	4.594	+0.002	+0.04%
U.S. 5Y	4.591	-0.022	-0.47%
U.S. 2Y	4.902	-0.037	-0.75%

Lloyds Banking	52.06	-0.14	-0.27%
Vodafone Group PLC	67.820	+0.340	+0.50%
Barclays	201.00	-2.45	-1.20%
BT Group	103.55	-0.30	-0.29%
HSBC	705.00	+7.50	+1.08%
BHP Group Ltd	2,232.00	+25.00	+1.13%
Exxon Mobil	116.20	+0.17	+0.15%

Recent Quotes

	Name	Price	Chg.	Chg. %
	GTHX	4.375	+0.245	+5.93%

Market Movers

Name	Last	Chg. %	Vol.
NatWest Group	303.20	-0.53%	60.76M
Rolls-Royce Holdings	406.50	-0.25%	48.71M
Glencore	458.70	-1.67%	46.26M
Imperial Brands	1,843.50	+0.49%	10.26M
Shell	2,873.0	+1.92%	7.95M
Rio Tinto PLC	5,442.0	+0.30%	3.85M
AstraZeneca	12,156.0	-0.12%	1.96M

Name	Last	Chg. %	Vol.
Edgio	9.60	+100000.00%	0.56K
DMK Pharmaceuticals	0.03	+100000.00%	0.02K
AAC Clyde Space	49.00	+100000.00%	0.00K
Synlogic	1.85	+100000.00%	0.01K
MyMD Pharmaceuticals	3.13	+100000.00%	0.01K
MFE MEDIAFOREUROPE NV B	3.820	+215.96%	11.50K
Frontline	264.30	+133.27%	0.36K

Name	Last	Chg. %	Vol.
H Lundbeck B	33.48	-80.73%	3.37K
BioGaia B	113.30	-78.02%	1.77K
Hydrogen Refueling	5.11	-65.29%	0.02K
Surface Transforms	1.08	-62.46%	95.65M
Tomra Systems	136.50	-60.75%	9.58K
Ekinops SA	3.23	-58.27%	0.38K
Atlas Copco B	165.15	-56.29%	29.00K